Editorial

Loco-Regional Treatment for Intact Primary Tumor in Patient with De Novo Metastatic Breast Cancer; Comments and Concerns of ECOG-ACRIN 2108 Trial
  • Atilla Soran
  • Serdar Özbaş
  • Lütfi Doğan
  • Efe Sezgin
  • Vahit Özmen
  • Sushil Beriwal
  • Adam Brufsky
Eur J Breast Health 2020; 16: 158-159 DOI: 10.5152/ejbh.2020.080620

Review

TRASTUZUMAB BEYOND PROGRESSION IN PATIENTS WITH HER-2/NEU POSITIVE METASTATIC BREAST CANCER
  • Yeşim Eralp
Eur J Breast Health 2009; 5: 3-8
The Role of Primary Surgery in De Novo Metastatic Breast Carcinoma
  • Berkay Demirors
  • Berk Goktepe
  • Hannah Medeck
  • Serdar Ozbas
  • Atilla Soran
Eur J Breast Health 2023; 19: 110-114 DOI: 10.4274/ejbh.galenos.2023.2023-3-7 PMID:37025581

Original Article

A Systematic Review and Pooled Analysis of Studies of Oral Etoposide in Metastatic Breast Cancer
  • Ioannis A. Voutsadakis
Eur J Breast Health 2018; 14: 10-16 DOI: 10.5152/ejbh.2017.3563
The Impact of the COVID-19 Pandemic on Breast Cancer Patients
  • Ahmet Serkan İlgün
  • Vahit Özmen
Eur J Breast Health 2022; 18: 85-90 DOI: 10.4274/ejbh.galenos.2021.2021-11-5 PMID:35059596
Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine
  • İzzet Doğan
  • Nail Paksoy
  • Naziye Ak
  • Sezai Vatansever
  • Pınar Saip
  • Adnan Aydıner
Eur J Breast Health 2023; 19: 128-133 DOI: 10.4274/ejbh.galenos.2023.2022-12-4 PMID:37025570
Factors Influencing Non-sentinel Node Metastasis in Patients with Macrometastatic Sentinel Lymph Node Involvement and Validation of Three Commonly Used Nomograms
  • Hikmet Erhan Güven
  • Lütfi Doğan
  • Mahmut Onur Kültüroğlu
  • Mehmet Ali Gülçelik
  • Cihangir Özaslan
Eur J Breast Health 2017; 13: 189-193 DOI: 10.5152/ejbh.2017.3545
Associated Features with Non-Sentinel Lymph Node Involvement in Early Stage Breast Cancer Patients who Have Positive Macrometastatic Sentinel Lymph Node
  • Hakan Ataş
  • Buket Altun Özdemir
  • Ebru Menekşe
  • Sabri Özden
  • Yunus Nadi Yüksek
  • Gül Dağlar
Eur J Breast Health 2020; 16: 192-197 DOI: 10.5152/ejbh.2020.5332
Clinical Significance of Radiologically Detected Small Indeterminate Extra-Mammary Lesions in Breast Cancer Patients
  • Rachel Yanlin Chen
  • Rui Ying Goh
  • Hoi Ting Leung
  • Stephanie Cheng
  • Veronique Kiak Mien Tan
  • Clement Luck Khng Chia
  • Jerry Tiong Thye Goo
  • Marc Weijie Ong
Eur J Breast Health 2022; 18: 252-257 DOI: 10.4274/ejbh.galenos.2022.2022-1-2 PMID:35855201
Effects of Primary Tumor Resection on Metastatic Breast Cancer Survival and the Predictive Power of Neutrophil: Lymphocyte Ratio on Prognosis
  • Yaşar Çöpelci
  • Umut Rıza Gündüz
  • Bülent Dinç
  • Nurhan Haluk Belen
  • Şeyda Gündüz
Eur J Breast Health 2021; 17: 322-327 DOI: 10.4274/ejbh.galenos.2021.2021-3-2 PMID:34651110

Case Report

METASTATIC MALIGNANT MELANOMA OF THE BREAST: A CASE REPORT
  • Olcay Ak Nalbant
  • Safiye Vural
  • M. Celalettin Keleş
  • Erdem Nalbant
  • Ali Rıza Kandiloğlu
Eur J Breast Health 2011; 7: 36-39
External Jugular Vein Thrombosis as a Sign of Metastatic Breast Cancer
  • Metin Yalaza
  • Mehmet Tolga Kafadar
  • Esra Yurduseven Çıvgın
  • Arife Polat Düzgün
Eur J Breast Health 2017; 13: 43-45 DOI: 10.5152/tjbh.2016.3315
Three Dimensional Modelling in the Optimisation of Chest Wall Resection and Reconstruction Following Metastatic Breast Cancer
  • Hanad Ahmed
  • Mansoor Khan
  • Aiman Alzetani
Eur J Breast Health 2022; 18: 286-288 DOI: 10.4274/ejbh.galenos.2022.2022-3-6 PMID:35855200

Letter to the Editor

Results of ECOG-ACRIN E2108 Trial: Is This the End of Primary Surgery in Metastatic Breast Cancer?
  • Paulo Luz
Eur J Breast Health 2021; 17: 84-85 DOI: 10.4274/ejbh.2020.6222 PMID:33796836